Press release
Biotechnology And Pharmaceutical Services Outsourcing Industry to See Robust Expansion, Valued at $94.91 Billion by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.What Is the Projected CAGR for the Biotechnology And Pharmaceutical Services Outsourcing Market from 2024 to 2025?
The market size for outsourcing services in biotechnology and pharmaceuticals has been experiencing robust growth in the past few years. Expectations indicate that the market value will rise from $66.87 billion in 2024 to $71.87 billion in 2025, marking a compound annual growth rate (CAGR) of 7.5%. The impressive growth during the historic period has been spurred by factors such as increased demand for expert therapeutic knowledge and global trial design, rising counts of orphan drug and rare disease trials, enhanced development of biologics and biosimilars, the growing utilization of laboratory testing and analytical services, and the expansion of virtual biotech companies.
What are the Expected Market Size and CAGR for Biotechnology And Pharmaceutical Services Outsourcing by 2029?
The market size for outsourcing services in biotechnology and pharmaceuticals is anticipated to witness significant expansion in the upcoming years, with projections suggesting it will increase to $94.91 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.2%. This anticipated growth within the forecast period can be credited to a rise in the pressure for prompt drug approvals, the internationalization of clinical research functions, an increase in global clinical trial volume, heightened outsourcing of phase I-IV trials, and a heightened emphasis on adaptive and decentralized trials. The forthcoming period will also see trends such as the implementation of cloud-based platforms for instantaneous collaboration, the application of AI and Machine Learning in drug discovery and refinement, advanced bioinformatics and data analytics, the integration of automation and robotics in lab services, and the utilization of electronic data capture systems.
Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/biotechnology-and-pharmaceutical-services-outsourcing-global-market-report
Which Factors Are Driving the Global Biotechnology And Pharmaceutical Services Outsourcing Market Expansion?
The escalating involvement in clinical research is anticipated to propel the expansion of the biotech and pharmaceutical services outsourcing market moving forward. Clinical research, a methodical inquiry involving human subjects aimed at enhancing comprehension of health-related issues and measuring the security and efficacy of medical interventions, is on the rise. The surge in clinical examination is significantly caused by the increasing prevalence of chronic illnesses, making it essential to create and evaluate new remedies for improved patient care. The outsourcing of biotech and pharmaceutical services lends a helping hand to clinical research by affording access to specialized knowledge and cutting-edge infrastructure, guaranteeing the execution of trials on a global spectrum that is efficacious, economical, and adheres to regulations. For example, in November 2023 as per the records of the Association of the British Pharmaceutical Industry, a trade union based on the UK, there was a 4.3% annual escalation in the count of industry-guided clinical trials in the UK, augmenting from 394 in 2021 to 411 in 2022. As such, the escalating activity in clinical research serves as a catalyst for the growth of the biotech and pharmaceutical services outsourcing market.
Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25709&type=smp
Which Segment Currently Holds the Largest Share of the Biotechnology And Pharmaceutical Services Outsourcing Market?
The biotechnology and pharmaceutical services outsourcing market covered in this report is segmented -
1) By Service: Consulting, Regulatory Affairs, Product Design And Development, Auditing And Assessment, Product Maintenance, Training And Education, Other Services
2) By Application: Oncology, Neurology, Cardiovascular, Infectious Diseases
3) By End-Use: Pharma, Biotech
Subsegments:
1) By Consulting: Strategic Consulting, Market Access Consulting, Commercialization Strategy, Portfolio Management, Technology And Digital Transformation Consulting
2) By Regulatory Affairs: Regulatory Submissions, Compliance And Risk Management, Product Registration, Labeling And Packaging Review, Regulatory Intelligence
3) By Product Design And Development: Formulation Development, Preclinical Development, Bioprocess Development, Analytical Development, Drug Delivery System Design
4) By Auditing And Assessment: Good Manufacturing Practice (GMP) Audits, Good Clinical Practice (GCP) Audits, Quality System Audits, Supplier And Vendor Audits, Risk Assessments
5) By Product Maintenance: Lifecycle Management, Change Management, Technical Support, Software And IT System Updates, Compliance Monitoring
6) By Training And Education: Regulatory Training, Good Laboratory Practice (GLP) Training, Pharmacovigilance Training, Clinical Trial Training, Quality Management Systems Training
7) By Other Services: Intellectual Property Support, Medical Writing, Data Management And Biostatistics, Pharmacovigilance And Drug Safety, Translation And Localization Services
Which Major Trends Are Shaping the Future of the Biotechnology And Pharmaceutical Services Outsourcing Industry?
Leading firms in the biotechnology and pharmaceutical services outsourcing sector are concentrating on developing innovative solutions such as cloud-based platforms to facilitate remote access and real-time collaboration. These are online systems that offer users the ability to tap into and utilize computing resources, like processing power, storage, and software without depending on local servers or gadgets. For example, in March 2023, Charles River Labs, a non-clinical contract research organization based in the US, introduced Apollo, a cloud-based platform designed to enhance toxicology studies. This allows clients to easily access vast array of study data, helping in safety and toxicology evaluations. The platform includes self-service capabilities that let users independently track study progress, analyze data, and acquire crucial documents. A remarkable feature is its quote tool that aids in more precise and effective budget planning.
Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25709&type=smp
Which Key Players Dominate the Biotechnology And Pharmaceutical Services Outsourcing Industry Globally?
Major companies operating in the biotechnology and pharmaceutical services outsourcing market are Thermo Fisher Scientific Inc., Boehringer Ingelheim, LabCorp Holdings, IQVIA Inc., ICON plc., Eurofins Scientific SE, Lonza Group Ltd., Syneos Health, Catalent Inc., Charles River Laboratories, Samsung Biologics Co. Ltd., WuXi Biologics, Recipharm AB, Medpace Holdings Inc., Curia Inc., CordenPharma Corp., Parexel International Ltd., Lachman Consultants, Concept Heidelberg GmbH, The Quantic Group Ltd.
What Are the Fastest-Growing Regions in the Biotechnology And Pharmaceutical Services Outsourcing Market?
North America was the largest region in the biotechnology and pharmaceutical services outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology and pharmaceutical services outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
#Reach Out to Us#
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biotechnology And Pharmaceutical Services Outsourcing Industry to See Robust Expansion, Valued at $94.91 Billion by 2029 here
News-ID: 4156069 • Views: …
More Releases from The Business Research Company

Asthma Therapeutics Industry Set to Achieve $44.53 Billion Milestone by 2029 | S …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Asthma Therapeutics Market Size 2025?
There has been significant growth in the market size of asthma therapeutics in recent times. The market will escalate from $30.63 billion in 2024 to $33.11 billion in 2025, boasting a compound annual growth rate (CAGR) of 8.1%. This…

Anti-Inflammatory Biologics Market to Surpass $166.28 Billion by 2029 | Key Tren …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Anti-Inflammatory Biologics Market Grow by 2025 in Terms of Size and Growth?
In recent times, there has been significant growth in the size of the anti-inflammatory biologics market. The market, which is projected to increase from $108.11 billion in 2024 to $118.02 billion in 2025,will witness a compound…

Acute Care Telemedicine Market Size to Reach $66.59 Billion by 2029 | Growth at …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Acute Care Telemedicine Industry?
The expansion of the acute care telemedicine market has been swift in the past few years. The market, which was valued at $28.34 billion in 2024, is projected to increase to $34.66 billion in 2025, following a compound annual…

2025-2034 Weapon Fuze Market Roadmap: Insights for Competitive Advantage
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Weapon Fuze Market Size By 2025?
The size of the weapon fuze market has seen significant growth in the past few years. It is projected to expand from $2.58 billion in 2024 to $2.77 billion in 2025, with a compound annual growth rate (CAGR) of…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…